Owkin’s machine learning tech to inform mesothelioma trialsA mesothelioma prognostic model from medical machine learning firm Owkin has been showcased in the journal Nature, and Share XOwkin’s machine learning tech to inform mesothelioma trialshttps://pharmaphorum.com/news/owkins-machine-learning-tech-gives-mesothelioma-prognosis-and-survival-insights/
BI drug named Promising Innovative Medicine in mesotheliomaBoehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for Share XBI drug named Promising Innovative Medicine in mesotheliomahttps://pharmaphorum.com/news/bi-drug-named-promising-innovative-medicine-mesothelioma/
